Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 17 Issue: 4 Year: 2017 Page: 276-284 Author(s): Nur-Vaizura Mohamad,Ima-Nirwana Soelaiman,Kok-Yong Chin
Ebook: Frontiers in Drug Design and Discovery Volume: 8 Year: 2017 Author(s): Patricia Tai,Evgeny Sadikov,Asim Amjad,Nelson Leong,Arbind Dubey,Wojciech Dolata,Miroslav Jancewicz,Rashmi Koul Doi: 10.2174/9781681083551117080005
Journal: Current Cancer Drug Targets Volume: 15 Issue: 4 Year: 2015 Page: 314-326 Author(s): Yasuhide Kitagawa,Satoru Ueno,Hiroyuki Konaka,Atsushi Mizokami,Shiro Hinotsu,Hideyuki Akaza,Mikio Namiki
Journal: Anti-Cancer Agents in Medicinal Chemistry Volume: 9 Issue: 1 Year: 2009 Page: 1046-1051 Author(s): Nima Sharifi
Journal: Current Neuropharmacology Volume: 15 Issue: 7 Year: 2017 Page: 1043-1055 Author(s): Erik Wibowo
Journal: Current Drug Targets Volume: 22 Issue: 1 Year: 2021 Page: 68-76 Author(s): Alessandro Tafuri,Maria Angela Cerruto,Alessandro Antonelli
Journal: Recent Patents on Anti-Cancer Drug Discovery Volume: 2 Issue: 3 Year: 2007 Page: 203-211 Author(s): Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama
Journal: Current Drug Targets Volume: 14 Issue: 4 Year: 2013 Page: 420-440 Author(s): Michael V. Fiandalo, Wenjie Wu, James L. Mohler
Ebook: Frontiers in Anti-Cancer Drug Discovery Volume: 1 Year: 2010 Author(s): Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama Doi: 10.2174/978160805161811001010481
Journal: Current Cancer Therapy Reviews Volume: 7 Issue: 3 Year: 2011 Page: 201-214 Author(s): Vallejo Herrador J., Martinez-Pineiro L.
Previous Next